News

View BioWin’s press releases and latest announcements.

 

Filter

BioWin Day: empowering health

June 2, 2023

The 40th call for collaborative R&I projects is now open!

May 4, 2023

Sponsorship Opportunities – BioWin day: empowering health

April 13, 2023

Belgian biotech companies DeuterOncology and Radiomics combine their expertise to improve cancer therapy

April 7, 2023

Supporting a thriving Belgian medtech industry: dedicated initiatives for an innovative ecosystem (Part 1)

April 6, 2023

Mark your calendars for BioWin Day: empowering health

March 31, 2023

ImmuneWatch, Quantoom Biosciences (Univercells) and UAntwerp join forces to explore new in vitro and in silico assays that predict T cell responses in vaccines

March 30, 2023

Save the Date HealthTech Innovation Days 2023

March 30, 2023

Wallonia, champion in the fight against cancer

March 20, 2023

Quantoom Biosciences is growing in France with brand-new facilities for its DNA and enzymes activity located in Evry (Région Île-de-France)

March 3, 2023

BioWin announces Damien Diop as its new manager of international affairs

February 21, 2023

ABSCINT and the VUB announce a Notice of Allowance for their U.S. Patent covering diagnostic applications of its single-domain antibody labelled with radioisotopes for PET/CT imaging of HER2 cancer lesions

February 21, 2023

TRASIS closes a record year in 2022 with a +50% growth in sales

February 20, 2023

Weber joins Vivactis Group to reinforce its Market Access capabilities

February 2, 2023

Groundbreaking ceremony at Aseptic Technologies!

January 30, 2023

Cellaion SA announces a total fundraising of EUR 23 million in 2022

January 17, 2023

La Belgique renforce sa position stratégique dans le secteur pharmaceutique grâce à un entrepôt ultramoderne

December 21, 2022

BioWin is moving its headquarters to Namur, right in the heart of Wallonia

December 20, 2022

Analis takes over VOS instrumenten

December 13, 2022

Horizon-Europe: a great funding opportunity for BioWin members!

December 2, 2022

BioWin expands its ‘Growth & Financing’ member service by appointing two industry experts

November 29, 2022

HealthTech For Care looks back on its first pitch competition during the HealthTech Innovation Days

October 28, 2022

The Belgian health ecosystem shows a strong dedication to the European Event HealthTech Innovation Days on 13-14 October in Paris

October 6, 2022

The 37th call for collaborative R&I projects is now open!

June 15, 2022

BioWin, CETIC and essenscia wallonie launch the BioMan initiative to accelerate the digitalization of bioprocesses in Wallonia

June 14, 2022

Belgian Economic Mission to the USA #BEmissionUSA

June 3, 2022

BioWin celebrated 15y of health innovations !

May 19, 2022

BioWin spearheads `Talent Now’, a unique initiative to tackle recruitment shortages and challenges in the healthtech industry

May 3, 2022

SURVEY – Webinar: How is AI changing clinical development?

April 28, 2022

Belgian Economic Mission to the United Kingdom #BemissionUK

April 27, 2022

Help us to improve our newsletter !

February 18, 2022

Transnational EU-project CE4BIG on cluster management excellence and SME support draws to a close

February 2, 2022

BioWin Day 2021 – Give your feedback !

December 9, 2021

BioWin Day

December 9, 2021

SURVEY – MedTech in Belgium : Understanding the current landscape and the impact of the EU-MDR on your day-to-day business

December 1, 2021

The 39th call for collaborative R&I projects is now open

November 22, 2021

Throwback on the first edition of the MedTech Wallonia Day!

October 28, 2021

Pan-European Biomanufacturing Landscape

October 13, 2021

Throwback on BioWin & AGIO Capital & Business Solutions’ workshop

October 7, 2021

Takeda inaugurates new state-of-the-art biotechnology production facility at its Lessines site in Belgium

September 1, 2021

BioWin has been internationally recognized for its Cluster Management Excellence and obtained the Silver quality label from the European Secretariat for Cluster Analysis (ESCA)

August 30, 2021

HealthTech For Care and EIT Health publish the agenda of the 3rd edition of the HealthTech Innovation Days event next 4 & 5 October 2021

July 6, 2021

Walloon company Promethera announces a €20 millions financing round

June 30, 2021

Univercells unveils new brand identity and logo

June 30, 2021

Feu vert pour le ‘EU Biotech School & Health Hub’ à Gosselies

June 30, 2021

The Belgian Biopharma sector, key player in an innovative ecosystem

June 28, 2021

ULB HelSci launches an INTERUNIVERSITY CERTIFICATE IN VACCINOLOGY

June 24, 2021

IBA Launches Versatile High-Energy New Cyclotron

June 17, 2021

Online conference, HealthTech For Patients

June 17, 2021

The 34th call for collaborative R&I projects is now open!

June 15, 2021

15 years of innovation … and ambitions for tomorrow!

June 3, 2021

Industry 4.0 for biomanufacturing: discover the webinar replay of April 29, 2021

May 21, 2021

MAGIA2market: You are a Medtech company? Tell us about your international needs !

May 6, 2021

HealthTech For Care and EIT Health announce the opening of applications for European companies

April 8, 2021

Graftys Announces New Manufacturing & Logistic Site in Liège (Belgium)

March 30, 2021

Orgenesis Enters into Collaboration Agreement with the Bambino Gesù Children’s Hospital in Rome to Establish Point of Care Cell and Gene Therapy Center

March 29, 2021

CyanVac selects Exothera for the development and GMP manufacturing of its COVID-19 intranasal vaccine candidate for phase III clinical trial in Europe and the US

March 25, 2021

HealthTech For Care and EIT Health renew their partnership for the organisation of HealthTech Innovation Days, reinforcing its European positioning through new collaborations with BIO Deutschland and BioWin.

March 3, 2021

BioWin announces expanded role to consolidate Wallonia’s status as a dynamic region for life science innovation

March 2, 2021

BioWin took part in the eighteenth European Clusters Alliance webinar – Sept. 24, 2020

January 20, 2021

Launch of the 2nd call for collective projects Tremplin IA

January 18, 2021

Investment incentive: €20 million to support pharma and biotech companies active in the fight against COVID-19

January 18, 2021

Strategic mission to strengthen the talent pool of the sector

December 19, 2020

Strengths of the Life Sciences Ecosystem in Belgium-Wallonia

November 27, 2020

MAGIA2market: Call for Tender – Market Study on the Japanese MedTech Industry

November 13, 2020

News from our members

November 10, 2020

Latest news related to COVID-19

October 26, 2020

Discover BioWin’s collection on the mobilisation of the ecosystem’s members and the Government to fight the COVID-19 pandemic

October 15, 2020

BioWin welcomes Modis as a partner !

October 8, 2020

The MAGIA2Market European project has officially started !

October 6, 2020

BioWin is launching the 32nd Competitiveness Cluster call for R&I projects

September 29, 2020

COVID-19 news – July 2020

August 24, 2020

COVID-19 news – June 2020

August 24, 2020

The Walloon government approved 2 R&I projects

August 7, 2020

COVID-19 news – May 2020

June 2, 2020

COVID-19: Join BioWin’s cooperation platform!

May 26, 2020

What is BioWin doing during the COVID-19 crisis?

May 5, 2020

COVID-19 news – April 2020

May 5, 2020

Accessia pharma : a dedicated site for your GMP production

May 5, 2020

Launch of the European project CE4BIG

April 30, 2020

DNAlytics is currently involved in several projects related to the fight against COVID-19

April 29, 2020

COVID-19 news – March 2020

April 27, 2020

Mithra Announces Commercial Launch of Myring™ in Germany, the biggest market in Europe

April 8, 2020

BREAKING NEWS! iTeos Therapeutics closes $125 Million Series B2 Financing

April 2, 2020

Authorisation scheme for the export of medical equipment from the EU

March 19, 2020

Events and working process : update COVID-19

March 19, 2020

Ayming Belgium becomes the first partner of BioWin

January 6, 2020

BioWin is launching the 30th Competitive Cluster call for R&I projects

January 2, 2020

Bioxodes announces the initiation of a double blind, placebo controlled, single ascending dose phase I trial

October 15, 2019